240 related articles for article (PubMed ID: 17669688)
1. Rv1773 is a transcriptional repressor deleted from BCG-Pasteur.
Alexander DC; Behr MA
Tuberculosis (Edinb); 2007 Sep; 87(5):421-5. PubMed ID: 17669688
[TBL] [Abstract][Full Text] [Related]
2. Preparation of a working seed lot of BCG and quality control by PCR genotyping.
Trovero A; Argüelles C; Cataldi A
Rev Argent Microbiol; 2010; 42(1):4-10. PubMed ID: 20461286
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy and safety of vaccines against tuberculosis in the relation to genetic variability of Mycobacterium bovis BCG strains].
Prygiel M; Janaszek-Seydlitz W; Bucholc B
Przegl Epidemiol; 2011; 65(4):621-8. PubMed ID: 22390050
[TBL] [Abstract][Full Text] [Related]
4. Recombinant Mycobacterium bovis BCG.
Bastos RG; Borsuk S; Seixas FK; Dellagostin OA
Vaccine; 2009 Nov; 27(47):6495-503. PubMed ID: 19720367
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterium avium subsp. paratuberculosis-specific mpt operon expressed in M. bovis BCG as vaccine candidate.
Heinzmann J; Wilkens M; Dohmann K; Gerlach GF
Vet Microbiol; 2008 Aug; 130(3-4):330-7. PubMed ID: 18343053
[TBL] [Abstract][Full Text] [Related]
7. Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree.
Oettinger T; Jørgensen M; Ladefoged A; Hasløv K; Andersen P
Tuber Lung Dis; 1999; 79(4):243-50. PubMed ID: 10692993
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis.
Mahairas GG; Sabo PJ; Hickey MJ; Singh DC; Stover CK
J Bacteriol; 1996 Mar; 178(5):1274-82. PubMed ID: 8631702
[TBL] [Abstract][Full Text] [Related]
9. Role of M. tuberculosis RD-1 region encoded secretory proteins in protective response and virulence.
Ganguly N; Siddiqui I; Sharma P
Tuberculosis (Edinb); 2008 Nov; 88(6):510-7. PubMed ID: 18640874
[TBL] [Abstract][Full Text] [Related]
10. Comparative genomics of BCG vaccines by whole-genome DNA microarray.
Behr MA; Wilson MA; Gill WP; Salamon H; Schoolnik GK; Rane S; Small PM
Science; 1999 May; 284(5419):1520-3. PubMed ID: 10348738
[TBL] [Abstract][Full Text] [Related]
11. Whole genome sequence analysis of Mycobacterium bovis bacillus Calmette-Guérin (BCG) Tokyo 172: a comparative study of BCG vaccine substrains.
Seki M; Honda I; Fujita I; Yano I; Yamamoto S; Koyama A
Vaccine; 2009 Mar; 27(11):1710-6. PubMed ID: 19200449
[TBL] [Abstract][Full Text] [Related]
12. The immune response of the Chacma baboon to Bacille Calmette Guerin: development of a primate model for BCG-based vaccine research.
Chege GK; Williamson AL; Passmore JS; Bourn W; Ryffel B; Shephard EG
Vaccine; 2005 Dec; 23(50):5783-91. PubMed ID: 16214269
[TBL] [Abstract][Full Text] [Related]
13. An esat6 knockout mutant of Mycobacterium bovis produced by homologous recombination will contribute to the development of a live tuberculosis vaccine.
Wards BJ; de Lisle GW; Collins DM
Tuber Lung Dis; 2000; 80(4-5):185-9. PubMed ID: 11052907
[TBL] [Abstract][Full Text] [Related]
14. Differences in nitrate reduction between Mycobacterium tuberculosis and Mycobacterium bovis are due to differential expression of both narGHJI and narK2.
Sohaskey CD; Modesti L
FEMS Microbiol Lett; 2009 Jan; 290(2):129-34. PubMed ID: 19076631
[TBL] [Abstract][Full Text] [Related]
15. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
Sun R; Skeiky YA; Izzo A; Dheenadhayalan V; Imam Z; Penn E; Stagliano K; Haddock S; Mueller S; Fulkerson J; Scanga C; Grover A; Derrick SC; Morris S; Hone DM; Horwitz MA; Kaufmann SH; Sadoff JC
Vaccine; 2009 Jul; 27(33):4412-23. PubMed ID: 19500523
[TBL] [Abstract][Full Text] [Related]
16. Evidence for enhanced central memory priming by live Mycobacterium bovis BCG vaccine in comparison with killed BCG formulations.
Whelan AO; Wright DC; Chambers MA; Singh M; Hewinson RG; Vordermeier HM
Vaccine; 2008 Jan; 26(2):166-73. PubMed ID: 18055073
[TBL] [Abstract][Full Text] [Related]
17. Anti-tuberculosis drug susceptibility testing of Mycobacterium bovis BCG Tokyo strain.
Shishido Y; Mitarai S; Otomo K; Seki M; Sato A; Yano I; Koyama A; Hattori T
Int J Tuberc Lung Dis; 2007 Dec; 11(12):1334-8. PubMed ID: 18034955
[TBL] [Abstract][Full Text] [Related]
18. Genome sequence of Mycobacterium bovis BCG Moreau, the Brazilian vaccine strain against tuberculosis.
Gomes LH; Otto TD; Vasconcellos EA; Ferrão PM; Maia RM; Moreira AS; Ferreira MA; Castello-Branco LR; Degrave WM; Mendonça-Lima L
J Bacteriol; 2011 Oct; 193(19):5600-1. PubMed ID: 21914899
[TBL] [Abstract][Full Text] [Related]
19. Microevolution of BCG substrains.
Krysztopa-Grzybowska K; Lutyńska A
Postepy Hig Med Dosw (Online); 2016 Dec; 70(0):1259-1266. PubMed ID: 28026828
[TBL] [Abstract][Full Text] [Related]
20. Failure of a Mycobacterium tuberculosis DeltaRD1 DeltapanCD double deletion mutant in a neonatal calf aerosol M. bovis challenge model: comparisons to responses elicited by M. bovis bacille Calmette Guerin.
Waters WR; Palmer MV; Nonnecke BJ; Thacker TC; Scherer CF; Estes DM; Jacobs WR; Glatman-Freedman A; Larsen MH
Vaccine; 2007 Nov; 25(45):7832-40. PubMed ID: 17931755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
